Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Immunotherapy · Australia · 2022-03-25

Processing Time
55 days
Decision Date
2022-03-25
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to enhance cell-based therapies in preclinical and clinical stages by developing high-throughput technologies to assess and identify immune cells with a high degree of accuracy. This work focuses on advancing cancer therapeutics by elucidating the role of extracellular vesicles (EVs) in cancer metastasis.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research significantly advances cancer therapeutics and has received funding from major federal agencies like the NIH and NSF.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a record of 4 peer-reviewed publications and 75 citations, indicating a history of successful research in the field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to cancer treatment are of such value that they benefit the U.S. even if other qualified workers are available.

Why This Petition Was Approved

The petition was approved based on the petitioner's 4 peer-reviewed journal articles and 75 citations, demonstrating a record of successful research. The case was supported by 4 expert recommendation letters and evidence of research funding from the NIH and NSF, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Mexico

WeGreened EB-2 (NIW) approved
Maryland 489 days 2022-08-22
The petitioner proposes to develop a highly quantitative understanding of the interactions between cancer cells and the immune system. He utilizes high-resolution microscopy, high-throughput flow cytometry, and mathematical modeling to design personalized cancer immunotherapies that are more effective than current treatments.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Australia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 55 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Australia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist